Omeros | OMER - Trade Debtors


Omeros reported $8.08M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Adma Biologics USD 158.43M 20.76M Dec/2025
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Cytokinetics USD 17.76M 15.96M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Immunic USD 333K 156K Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
MacroGenics USD 13.37M 55.86M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 125.64M 1.57M Mar/2026
Pfizer USD 15.84B 2.27B Dec/2025
Rockwell Medical USD 10.84M 250K Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Xoma USD 14.78M 4.96M Jun/2024